| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.79B | 8.39B | 6.61B | 5.75B | 4.76B | 3.58B |
| Gross Profit | 3.61B | 3.06B | 1.88B | 2.28B | 1.63B | 1.08B |
| EBITDA | 1.13B | -1.67B | 558.00M | 1.03B | 890.92M | 653.30M |
| Net Income | -2.72B | -2.70B | -422.30M | 557.39M | 495.74M | 310.46M |
Balance Sheet | ||||||
| Total Assets | 17.51B | 18.21B | 19.25B | 10.79B | 8.71B | 6.57B |
| Cash, Cash Equivalents and Short-Term Investments | 2.56B | 2.25B | 1.63B | 1.44B | 2.15B | 1.18B |
| Total Debt | 10.36B | 10.37B | 9.21B | 3.68B | 2.62B | 3.79B |
| Total Liabilities | 12.46B | 12.79B | 11.64B | 5.56B | 4.12B | 5.05B |
| Stockholders Equity | 5.05B | 5.41B | 7.61B | 5.23B | 4.59B | 1.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -775.41M | -2.72B | -1.62B | -382.82M | 281.26M |
| Operating Cash Flow | 0.00 | 885.16M | -953.77M | -119.25M | 443.38M | 568.30M |
| Investing Cash Flow | 0.00 | -1.54B | -6.14B | -1.73B | -849.16M | -300.64M |
| Financing Cash Flow | 0.00 | 1.28B | 7.30B | 1.12B | 1.38B | 241.38M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥25.66B | 14.51 | ― | 3.16% | 12.72% | 53.85% | |
78 Outperform | ¥20.97B | 9.36 | ― | 3.12% | 6.60% | 0.27% | |
77 Outperform | ¥27.29B | 11.51 | ― | 2.35% | 5.15% | 480.70% | |
71 Outperform | ¥11.49B | 6.59 | ― | 1.66% | 12.23% | 65.42% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | ¥20.03B | -7.06 | ― | ― | 36.90% | -311.02% | |
41 Neutral | ¥8.69B | -0.67 | ― | ― | ― | ― |
OXIDE Corporation reported the December 2025 exercise status of its 3rd series stock acquisition rights, with 7,000 shares delivered through the exercise of seven stock option units during the month. The 3rd series options reached the end of their exercise period on December 22, 2025, leaving 62 unexercised rights (equivalent to 62,000 shares) that were extinguished, thereby reducing the company’s potential dilutive shares by the same amount. As of the end of December, the company had 11,563,113 issued shares excluding dilutive securities and 572,000 remaining dilutive shares from stock acquisition rights, for a total of 12,135,113 shares on a fully diluted basis, providing investors with updated visibility into its equity base and dilution profile.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1578.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation reported a disappointing financial performance for the first half of the fiscal year, primarily due to challenges faced by its subsidiary, Raicol, amidst geopolitical conflicts. However, the company remains optimistic about a recovery in the second half, citing expected improvements in R&D subsidy timing, manufacturing costs, and revenue recovery, which could lead to a balanced operating profit.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1785.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation announced a non-operating income due to a foreign exchange gain of JPY 210 million for the second quarter of the fiscal year ending February 2026. This gain was primarily due to the revaluation of intra-group loans and foreign exchange forward contracts. Despite this gain, the company has not revised its annual forecast, as future exchange rate fluctuations could impact financial outcomes.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1785.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation reported its consolidated financial results for the six months ended August 31, 2025, showing a 22.1% increase in net sales compared to the previous year, despite operating and ordinary losses. The company’s financial position remains stable with a slight improvement in the equity ratio, and it maintains its dividend forecast unchanged, indicating a cautious yet optimistic outlook for the fiscal year ending February 28, 2026.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1785.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.